SAKK/Pfizer Award

Every two years the Swiss Group for Clinical Cancer Research (SAKK) awards a prize for patient-oriented, practical clinical cancer research with financial support of Pfizer AG. The prize is worth CHF 20,000.

Application

Individuals up to 50 years of age who work in clinical cancer research in Switzerland are eligible to apply. Applicants are asked to submit their research work in the form of a scientific paper that has been submitted to or already published in a peer-reviewed journal within the past year. The paper may not be more than a year old at the time of submission deadline and it must include specific proposals for improving the treatment and the therapeutic results that are achievable in cancer patients.

Submissions: Applications have to be submitted electronically via SAKK, events@sakk.ch.
Application for 2025 will be opened at the end of 2024.

For further information please refer to the documents below.

In collaboration with